A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Associate Director - Medical Value, Evidence, and Outcomes

Biology & BiotechConfirmed live in the last 24 hours
Full-timePasadena, CA, USA$180k - $210k

About the Job

Requirements

  • An advanced degree in health economics, health outcome research, epidemiology, public health, pharmacy, biostatistics, or a related field is required; listed qualifications include MSc, MPH, PharmD, PhD, or MD.
  • At least 5 years of industry experience in outcomes research, real-world evidence, medical affairs, market access, health economics, epidemiology, or a related function.
  • Ability to interpret clinical, real-world, epidemiologic, and economic evidence and translate complex concepts into clear written and verbal communications.
  • Project management skills, including managing multiple priorities, timelines, stakeholders, and vendor deliverables in a fast-paced environment.
  • Ability to work effectively in a matrixed, cross-functional environment.
  • Attention to detail, scientific judgment, communication skills, and commitment to compliant, high-quality execution.
  • Ability to manage multiple countries and priorities simultaneously in a fast-paced, evolving environment.
  • Ability to work independently and as part of a team.
  • Willingness to travel as necessary.
  • Authorization to work in the United States for a company is required.

Responsibilities

  • Support development and execution of real-world evidence and outcome research studies for the cardiometabolic pipeline, aligned with medical and payer evidence needs.
  • Contribute to study concept development, protocol review, vendor engagement, project timelines, data interpretation, and dissemination planning for MVEO initiatives.
  • Help develop and review scientific resources, including real-world evidence summaries, epidemiology assessments, budget impact inputs, and payer-facing medical materials.
  • Partner with Market Access and field medical colleagues to support medically focused payer discussions and ensure materials are scientifically accurate, balanced, and compliant.
  • Collaborate with the publications team to support abstracts, manuscripts, congress presentations, and other external communications related to real-world evidence and outcome research.
  • Conduct literature reviews, landscape assessments, and horizon scanning to identify evidence gaps and emerging trends in cardiometabolic disease, dyslipidemias, and RNA interference therapeutics.
  • Review clinical development plans to assist with endpoint strategies and analytic approaches that align evidence generation with medical, payer, and stakeholder needs.
  • Manage day-to-day relationships with external vendors and consultants, including tracking milestones, deliverables, budgets, and internal review processes.
  • Ensure activities comply with company policies, applicable laws, regulations, and compliance requirements.

Desired Qualifications

  • Experience in cardiometabolic disease, dyslipidemias, rare disease, RNA interference, or specialty therapeutics.
  • High proficiency in R, SAS, and Python.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs